To elucidate the regulatory role of BRD7 in modulating m6A modification, we investigated its effect on the expression levels of m6A methyltransferases (METTL3, METTL14, and WTAP) and demethylases (ALKBH5 and FTO) in NPC cells using western blot analysis. The gene discussed is MBD2; the disease is nasopharyngeal carcinoma.